Sutro Biopharma Gets $36.5M

San Francisco-based Sutro Biopharma, a developer of protein therapeutics technology, said today that it has raised $36.5M in a Series C funding round. The round was led by Skyline Ventures, and also included Lilly ventures, Amgen Ventures, SV Life Sciences, and Alta Partners. The firm said the funding will go towards its ongoing development and to advance its biochemical protein synthesis platform. Lilly Venturse' Leon Chen and Armen Shanafelt join the firm's board along with the funding. More information »